CEFAZOLIN
CEFAZOLIN FOR INJECTION, USP
Approved
Approval ID
922fb1a1-ad4c-4a12-8d5d-00fe13af18e8
Product Type
HUMAN PRESCRIPTION DRUG LABEL
Effective Date
Jul 12, 2023
Manufacturers
FDA
Henry Schein Inc.
DUNS: 012430880
Products 1
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
cefazolin
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
NDC Product Code0404-9835
Application NumberANDA065047
Product Classification
M
Marketing Category
C73584
G
Generic Name
cefazolin
Product Specifications
Route of AdministrationINTRAMUSCULAR, INTRAVENOUS
Effective DateJanuary 9, 2022
FDA Product Classification
INGREDIENTS (1)
CEFAZOLIN SODIUMActive
Quantity: 225 mg in 1 mL
Code: P380M0454Z
Classification: ACTIM